`

Beacon Therapeutics

Biotechnology Research

Last Updated: November 20, 2025
Sign Up to View More
Revenue
$2.30K
funding-icon Total Funding
$120.14M
Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs
Recent News

Frequently Asked Questions About Beacon Therapeutics

What does Beacon therapeutics do?+

Beacon Therapeutics is an ophthalmic gene therapy company founded in 2023 to save and restore the vision of patients with a range of prevalent and rare retinal diseases that result in blindness. The Company has an established scientific foundation that combines a late-stage development candidate to treat X-linked retinitis pigmentosa (XLRP), as well as two preclinical programs, one targeting dry age-related macular degeneration (AMD) and another targeting cone-rod dystrophy (CRD), an inherited retinal disease. Lead development candidate AGTC-501, is a gene therapy program in Phase II clinical trials for the treatment of XLRP, an inherited monogenic recessive disorder that causes...

What is Beacon therapeutics's industry? +

Beacon therapeutics operates in the Biotechnology research industry.

What is Beacon therapeutics's revenue? +

Beacon therapeutics's revenue is $2.30k

What is Beacon therapeutics's company size? +

Beacon therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free